Few instances of treatment-emergent resistance to bictegravir have been reported in the literature. We describe a case of treatment-emergent resistance to bictegravir in a person recently diagnosed with human immunodeficiency virus who developed M184V and R263K mutations while on therapy.
Keywords: HIV; R263K; bictegravir; resistance.
© The Author(s) 2021. Published by Oxford University Press on behalf of Infectious Diseases Society of America.